Nifidipine half life
Reading File
Searching the Web
nifedipine half life pharmacokinetics IR vs ER
Finding Sources
Reading File
Reading File
Here is a complete summary of nifedipine's half-life across formulations, drawn from multiple authoritative textbooks:
Nifedipine Half-Life by Formulation
| Formulation | Half-Life | Dosing Frequency |
|---|---|---|
| Immediate-Release (IR) capsule | ~2 hours (range 1.5-4 h) | Every 6-8 hours |
| PA (Procardia) - extended-release | ~10 hours | Twice daily |
| XL/GITS - once daily ER | ~24 hours | Once daily |
| ER (investigational/OROS) | 5-12 hours | Once or twice daily |
Key Pharmacokinetic Details
- Oral bioavailability: 45-70% (IR); 10-30% (ER formulations due to controlled release)
- Peak plasma concentration (IR): within 30-90 minutes of oral administration
- IV administration: Biphasic elimination - alpha phase ~13 min, beta phase ~1.26 hours
- Protein binding: ~95%
- Metabolism: Extensively hepatic (CYP3A4), producing inactive metabolites
- Placental transfer: Occurs within 2-3 hours after oral administration
Clinical Significance
The short half-life of IR nifedipine (~2 h) is clinically important:
- It causes rapid, steep drops in blood pressure, which can trigger reflex tachycardia, myocardial ischemia, and stroke
- The FDA has issued multiple warnings against using IR nifedipine for acute blood pressure lowering (sublingual or oral bite-and-swallow)
- ER formulations (XL/GITS with ~24 h half-life) provide smoother, sustained blood pressure control and are preferred for hypertension and angina
- Never crush ER tablets - this rapidly releases the full daily dose and can be fatal
Sources: Katzung's Basic and Clinical Pharmacology 16e; Goldman-Cecil Medicine; Brenner & Rector's The Kidney; Creasy & Resnik's Maternal-Fetal Medicine
Acth injection half life
Finding Sources
Searching the Web
ACTH injection half life pharmacokinetics corticotropin
Reading File
Reading File
Here is a complete answer on ACTH's half-life, drawn from authoritative textbooks:
ACTH (Corticotropin) - Half-Life
Endogenous / IV ACTH
| Source | Half-Life |
|---|---|
| Circulating endogenous ACTH (in vivo) | ~10 minutes |
| Full-length ACTH (39 amino acids) | 10-15 minutes |
| Cosyntropin (synthetic ACTH 1-24) | ~15 minutes |
"ACTH is inactivated in blood in vitro more slowly than in vivo; its half-life in the circulation in humans is about 10 min."
- Ganong's Review of Medical Physiology, 26th Ed.
Formulation-Dependent Half-Life
| Formulation | Half-Life / Duration | Notes |
|---|---|---|
| IV bolus (natural/synthetic) | ~10-15 min | Very rapid clearance |
| IM injection (aqueous) | ~15-30 min effective | Faster absorption than depot |
| Repository corticotropin injection (RCI / H.P. Acthar Gel) | Hours to days (slow release) | Depot gel - prolonged absorption from injection site |
Why the Half-Life Is So Short
- ACTH is a 39-amino acid polypeptide derived from POMC (pro-opiomelanocortin)
- Biological activity resides in residues 1-18; the C-terminal tail (residues 24-39) mediates the circulating half-life
- Rapid enzymatic degradation in plasma and tissues (primarily kidneys)
- Short half-life + pulsatile secretion = why random plasma ACTH measurements are generally unreliable for clinical diagnosis
Clinical Relevance
- The ACTH stimulation test (Cosyntropin 250 mcg IV/IM) achieves maximal adrenal stimulation by 30 minutes, despite the hormone's short half-life, because even a brief pulse saturates adrenocortical receptors
- Because of its short half-life, blood samples for ACTH measurement must be collected in chilled EDTA tubes and processed rapidly on ice to prevent ex vivo degradation
Sources: Ganong's Review of Medical Physiology 26e; Tietz Textbook of Laboratory Medicine 7e; Goldman-Cecil Medicine; Labcorp Cosyntropin reference
This is a shared conversation. Sign in to Orris to start your own chat.